Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Profit After Tax (2010 - 2026)

Vericel (VCEL) posted Profit After Tax of $2.2 million for Q2 2026, up 135.0% sequentially from -$6.3 million in Q1 2026, and up 498.92% YoY from $368332.7 in Q2 2025.

Analysis

Vericel (VCEL) Profit After Tax (2010 - 2026) Analysis & Trends

Vericel has reported Profit After Tax for 17 years, with the latest figure at $2.2 million in Q2 2026.

  • Quarterly Profit After Tax rose 498.92% year-over-year to $2.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $24.2 million (up 240.8% YoY) and the FY2025 annual result came in at $16.5 million, up 59.41% from the prior year.
  • Profit After Tax grew to $2.2 million in Q2 2026 per VCEL's latest filing, from -$6.3 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $23.2 million in Q4 2025 and troughed at -$11.2 million in Q1 2025.
  • A 5-year average of $160722.2 and a median of -$3.8 million in 2023 frame the typical range for Profit After Tax.
  • The widest YoY moves for Profit After Tax: up 663.15% in 2025, down 191.2% in 2025.
  • Over 5 years, Profit After Tax stood at $5.9 million in 2022, then surged by 119.4% to $13.0 million in 2023, then soared by 52.44% to $19.8 million in 2024, then grew by 17.35% to $23.2 million in 2025, then tumbled by 90.51% to $2.2 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered $2.2 million, -$6.3 million, and $23.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -644.37 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 81.49 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -16.62 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 2.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.21 Mn
Mar 31, 2026 -6.30 Mn
Dec 31, 2025 23.24 Mn
Sep 30, 2025 5.07 Mn
Jun 30, 2025 -553,000.00
Mar 31, 2025 -11.25 Mn
Dec 31, 2024 19.81 Mn
Sep 30, 2024 -901,000.00
Jun 30, 2024 -4.68 Mn
Mar 31, 2024 -3.86 Mn
Dec 31, 2023 12.99 Mn
Sep 30, 2023 -3.66 Mn
Jun 30, 2023 -5.02 Mn
Mar 31, 2023 -7.50 Mn
Dec 31, 2022 5.92 Mn
Sep 30, 2022 -6.58 Mn
Jun 30, 2022 -8.96 Mn
Mar 31, 2022 -7.09 Mn
Dec 31, 2021 4.54 Mn
Sep 30, 2021 -4.93 Mn